Calithera

Calithera BioSciences

This biopharmaceutical company develops small-molecule drugs targeting tumor metabolism and immunology to treat patients with various forms of cancer.

Akanocure Pharmaceuticals

This company develops small molecule drugs targeting orphan and unmet needs in oncology for healthcare providers and patients.

C4 Therapeutics

This biopharmaceutical company develops small-molecule medicines that degrade disease-causing proteins to treat cancer and other difficult diseases for patients and healthcare providers.

Dania Therapeutics

The company develops small-molecule therapies targeting cancer metabolism to treat acute myeloid leukaemia and other life-threatening cancers for medical patients.

Redona Therapeutics

This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.

Caldan Therapeutics

The company develops small-molecule drugs targeting free fatty acid receptors to treat metabolic diseases, such as type 2 diabetes, for the pharmaceutical industry.

Catalyst Oncology

The company provides clinical research services for oncology trials to biotechnology and pharmaceutical firms developing cancer treatments.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.